These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12586805)

  • 1. Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer.
    Roychowdhury DF; Hayden A; Liepa AM
    J Clin Oncol; 2003 Feb; 21(4):673-8. PubMed ID: 12586805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
    Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
    Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
    Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
    Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.
    Efficace F; Biganzoli L; Piccart M; Coens C; Van Steen K; Cufer T; Coleman RE; Calvert HA; Gamucci T; Twelves C; Fargeot P; Bottomley A;
    Eur J Cancer; 2004 May; 40(7):1021-30. PubMed ID: 15093577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
    Brandberg Y; Johansson H; Aamdal S; Bastholt L; Hernberg M; Stierner U; von der Maase H; Hansson J;
    Acta Oncol; 2013 Aug; 52(6):1086-93. PubMed ID: 23621752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.
    Urba S; Gatz J; Shen W; Hossain A; Winfree K; Koustenis A; Peterson P; Cohen EE
    Oral Oncol; 2012 Aug; 48(8):723-9. PubMed ID: 22414289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
    Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
    J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
    Efficace F; Innominato PF; Bjarnason G; Coens C; Humblet Y; Tumolo S; Genet D; Tampellini M; Bottomley A; Garufi C; Focan C; Giacchetti S; Lévi F;
    J Clin Oncol; 2008 Apr; 26(12):2020-6. PubMed ID: 18421055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
    Efficace F; Therasse P; Piccart MJ; Coens C; van Steen K; Welnicka-Jaskiewicz M; Cufer T; Dyczka J; Lichinitser M; Shepherd L; de Haes H; Sprangers MA; Bottomley A
    J Clin Oncol; 2004 Aug; 22(16):3381-8. PubMed ID: 15310784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials.
    Ediebah DE; Quinten C; Coens C; Ringash J; Dancey J; Zikos E; Gotay C; Brundage M; Tu D; Flechtner HH; Greimel E; Reeve BB; Taphoorn M; Reijneveld J; Dirven L; Bottomley A;
    Cancer; 2018 Aug; 124(16):3409-3416. PubMed ID: 29905936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.
    Kramer JA; Curran D; Piccart M; de Haes JC; Bruning P; Klijn J; Van Hoorebeeck I; Paridaens R
    Eur J Cancer; 2000 Aug; 36(12):1498-506. PubMed ID: 10930797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
    Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ
    J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
    Efficace F; Bottomley A; Coens C; Van Steen K; Conroy T; Schöffski P; Schmoll H; Van Cutsem E; Köhne CH
    Eur J Cancer; 2006 Jan; 42(1):42-9. PubMed ID: 16298522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
    Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
    Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention.
    Sugimoto H; Kawashima H; Ohno E; Hayashi D; Kuwahara T; Morishima T; Kawai M; Suhara H; Takeyama T; Yamamura T; Funasaka K; Nakamura M; Miyahara R; Watanabe O; Ishigami M; Suzuki M; Kimura H; Ozaki N; Hashimoto S; Goto H; Hirooka Y
    J Gastroenterol Hepatol; 2016 Mar; 31(3):685-90. PubMed ID: 26412310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
    Meyer F; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B; Bairati I
    J Clin Oncol; 2009 Jun; 27(18):2970-6. PubMed ID: 19451440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.